Premium
Frailty Syndrome in Heart Failure Patients who are Receiving Cardiac Resynchronization
Author(s) -
MLYNARSKA AGNIESZKA,
MLYNARSKI RAFAL,
BIERNAT JOLANTA,
SOSNOWSKI MACIEJ,
GOLBA KRZYSZTOF S.
Publication year - 2016
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/pace.12800
Subject(s) - medicine , cardiac resynchronization therapy , heart failure , cardiology , ejection fraction
Background We hypothesized that patients with de novo cardiac resynchronization therapy (CRT) implantation had a more intense frailty syndrome when compared to the patients who qualified for a system upgrade. Methods One hundred and six patients aged ≥65 years were included. They were divided into two groups: de novo CRT implantation—74 patients and upgrade from standard right heart pacing—32 patients. A CRT was finally implanted in all of the patients. Frailty was evaluated using the Canadian Study of Health and Aging Clinical Frailty Scale (CSHA‐CFS). Results The average results in CSHA‐CFS were statistically higher (5.3 ± 0.8) in the de novo patients when compared to the patients who qualified for a system upgrade (4.9 ± 0.8); P = 0.027. Frailty syndrome was recognized in 81.1% of the patients in the de novo group and in 68.7% of the patients in the upgrade group; P = 0.164. Only one patient of the 106 had no attributes of frailty (or exposed ones) syndrome. Conclusions Frailty syndrome is a common phenomenon in patients with heart failure and over 65 years of age. The syndrome is most often recognized in patients who are de novo qualified for cardiac resynchronization.